Gedik, K. C. Et Al. 2022. The 2021 EULAR and ACR points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS. ANNALS OF THE RHEUMATIC DISEASES , vol.81, no.5 , 601-613.

Gedik, K. C., Lamot, L., Romano, M., Demirkaya, E., Piskin, D., Torreggiani, S., ... Adang, L. A.(2022). The 2021 EULAR and ACR points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS. ANNALS OF THE RHEUMATIC DISEASES , vol.81, no.5, 601-613.

Gedik, Kader Et Al. "The 2021 EULAR and ACR points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS," ANNALS OF THE RHEUMATIC DISEASES , vol.81, no.5, 601-613, 2022

Gedik, Kader C. Et Al. "The 2021 EULAR and ACR points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS." ANNALS OF THE RHEUMATIC DISEASES , vol.81, no.5, pp.601-613, 2022

Gedik, K. C. Et Al. (2022) . "The 2021 EULAR and ACR points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS." ANNALS OF THE RHEUMATIC DISEASES , vol.81, no.5, pp.601-613.

@article{article, author={Kader Cetin Gedik Et Al. }, title={The 2021 EULAR and ACR points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS}, journal={ANNALS OF THE RHEUMATIC DISEASES}, year=2022, pages={601-613} }